Clinical Trials in Ovarian Cancer

Clinical Trials in Ovarian Cancer

Cancer

The first book to collect and synthesize cutting-edge research findings on the treatment of gynecological malignancies into one easy-to-use reference, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions.

Walsh, Christine

http://library.oapen.org/handle/20.500.12657/25278

https://www.rutgersuniversitypress.org/

Rutgers University Press

2017

Dewi Puspitasari

https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode

Aaronson NK, Ahmedzai S, Bergman B, et al. (1993). The Eu ro pean Organ ization
for Research and Treatment of Cancer QLQ- C30: a quality- of- life instrument
for use in international clinical trials in oncology. J Natl Cancer Inst.
85(5):365-376.

Aghajanian C, Blank SV, Goff BA, et al. (2012). OCEANS: a randomized, doubleblind,
placebo- controlled phase III trial of chemotherapy with or without bevacizumab
in patients with platinum- sensitive recurrent epithelial ovarian, primary
peritoneal, or fallopian tube cancer. J Clin Oncol. 30(17):2039-2045.

Pdf

English

Textbooks

DOI
10.2307/j.ctt1j7x9r2

ISBN
9780813586496;9780813586489

New Jersey